retatrutide safety trial results Looking forward to when #retatrutide's Phase 3 will become available. There are are 4 planned TRIUMPH trials investigating retatrutide's efficacy in treating obesity and its complications: #type2diabetes #cardiovascular disease Lilly's triple agonist, retatrutide, delivered

At iQ Doctor , you can access trusted menopause treatments and supplements to help you feel balanced, energised, and in control of your health again

Current clinical guidelines from major professional organizations provide evolving recommendations for pharmacologic management of weight regain after bariatric surgery

It was the most effective antidiabetic agent anyone had ever seen, says Andrew Young, former vice president of research at Amylin Pharmaceuticals, the San Diegobased company that brought Byetta to market

Wegovy is available in five different pre-filled, single-dose syringes including 0.25 mg, 0.5 mg, 1.0 mg, 1.7 mg, and 2.4 mg

When selecting a GLP-1 medication for a patient with Hashimoto's thyroiditis, there is no single "best" GLP-1 agonist specifically for this population